Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01251757 · ClinicalTrials.gov registry record · NA
Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 21,752
- Enrollment target
NCT01251757 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 21,752 participants.
The verdict
NCT01251757, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,752 participants
- Enrollment target
Study Summary
The purpose of this randomized clinical trial is to determine whether two low-intensity, technology based interventions, when compared to each other and to usual care, improve adherence to selected medications that are used to treat people with cardiovascular disease (CVD) and diabetes.
Interventions
- OTHER Interactive Voice Recognition (IVR) phone calls
- OTHER Educational mailings and follow-up for nonadherence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,752 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01251757
The ClinicalTrials.gov registry entry for NCT01251757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21,752 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Interactive Voice Recognition (IVR) phone calls is the first listed.
NCT01251757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01251757 about?
NCT01251757 is a clinical study titled "Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies". The purpose of this randomized clinical trial is to determine whether two low-intensity, technology based interventions, when compared to each other and to usual care, improve adherence to selected medications that are used to treat people with cardiovascular disease (CVD) and diabetes.
What is the current status of trial NCT01251757?
This trial is currently completed. It is a NA study. The enrollment target is 21,752 participants. The study started on 2011-08. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01251757?
The interventions under investigation include: Interactive Voice Recognition (IVR) phone calls (OTHER), Educational mailings and follow-up for nonadherence (OTHER).
Who is sponsoring clinical trial NCT01251757?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.